Mumbai: The Indian Council of Medical Research (ICMR) reported on Tuesday that there are three Indian COVID-19 vaccines in the country which are in various stages of clinical trials.
Dr. Balaram Bhargava, DG, ICMR while addressing a press conference here said,” Currently, we have three Indian vaccines which are in various stages of clinical trials. 2 vaccines – Bharat Biotech Vaccine and Zydus Cadila have completed phase 1 and will begin phase 2 while third is Oxford vaccine.”
“The Oxford vaccine, which is being manufactured by the Serum Institute of India (SII), has been approved for Phase 2 and 3 clinical trials, starting at 17 sites within a week,” he said.
However, Dr. Bhargava said that social disturbances and proper sanitation are the best “vaccines” available right now and beyond.
At the present moment, we have 3 Indian vaccines which are in different phases of clinical testing. The 2 vaccines- Bharat Biotech vaccine & DNA vaccine of Zydus Cadila have completed phase 1 and will begin phase 2 while third is Oxford vaccine: Dr Balram Bhargava, DG, ICMR pic.twitter.com/wcRuCZfzXe
— ANI (@ANI) August 4, 2020
“Body distance, wearing a mask, proper hand hygiene is the best vaccines available at this time and even beyond. We have to continue these measures,” he said.
A one-day spike of 52,050 COVID-19 cases was observed in India as the total number of cases in the country reached 18,55,746 on Tuesday.
The number of cured/discharged/migrated patients stands at 12,30,510 and 38,938 persons have died, the Health Ministry added.